T-CURX Appoints Florian Schmid as Chief Financial Officer
PRIVATESep 30, 2026
Position
Chief Financial Officer
Company
T-Curx
Florian Schmid
WürzburgBiotechnologyHealth Care
Description
T-CURX has appointed Florian Schmid as its new Chief Financial Officer. Schmid will focus on preparing and executing the company's planned financing activities while leading finance, operations, and investor relations functions.
Company Information
Company
T-Curx
Location
Würzburg, Bayern, Germany
About
T-Curx is a Würzburg, Germany-based biotech company focused on developing next-generation CAR-T cell therapies manufactured using non-viral technologies. The company aims to provide effective cancer therapies for patients suffering from acute myeloid leukemia (AML) and solid tumors. T-Curx utilizes proprietary non-viral CAR-T technologies for scalable and cost-effective manufacturing of CAR-T cells. It was spun out from the University Clinics Würzburg and is led by Ulf Grawunder, PhD.
Fundz sees it the moment T-Curx changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WürzburgBiotechnologyHealth Care